Regional Recurrence After Negative Sentinel Lymph Node Biopsy for Melanoma
- 1 September 2008
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Annals of Surgery
- Vol. 248 (3), 378-386
- https://doi.org/10.1097/sla.0b013e3181855718
Abstract
Objective: Sentinel lymph node (SLN) biopsy has shown great utility in the management of melanoma. An analysis of regional recurrence in previously mapped negative SLN basins as the first site of relapse is performed. Methods: A retrospective query of a prospective melanoma database from 1994 to 2006 identified 1287 patients who underwent successful SLN biopsy. One thousand sixty patients (82.4%) were SLN negative and 227 (17.6%) patients SLN positive. Clinical variables were examined for the impact on regional recurrence by multivariate analysis. Results: Mean follow-up was 44.3 months (range 3–155 months). Thirty-five patients (3.3%) presented with false-negative (FN) SLN biopsy. Pathologic review of the SLNs harvested from these basins found 7 (20.0%) samples positive for metastatic melanoma. Multivariate analysis found head and neck site [hazard ratio 3.67; 95% confidence interval (CI), 1.77–7.60, P < 0.001] and tumor thickness (hazard ratio 1.16; 95% CI, 1.04–1.30, P = 0.01) to be predictive of FN SLN biopsy. The 5-year melanoma specific survival calculated from the date of the SLN biopsy was 57.6% (95%CI, 35.7–41.9) in the FN group, which was not statistically different than the SLN positive group 60.0% (95% CI, 29.6–40.1; P = 0.14). Conclusions: Head and neck tumor site and tumor thickness are predictors of a FN SLN biopsy. Mechanisms other than pathologic SLN sampling error may contribute to the failure of the SLN biopsy in some patients. Patients with regional recurrence after negative SLN biopsy have a similar 5-year survival compared with patients with positive SLNs.Keywords
This publication has 23 references indexed in Scilit:
- Impact of False-Negative Sentinel Lymph Node Biopsy on Survival in Patients with Cutaneous MelanomaAnnals of Surgical Oncology, 2007
- Patterns of First-Recurrence and Post-recurrence Survival in Patients with Primary Cutaneous Melanoma After Sentinel Lymph Node BiopsyAnnals of Surgical Oncology, 2007
- Natural History of Melanoma in 773 Patients with Tumor-Negative Sentinel Lymph NodesAnnals of Surgical Oncology, 2007
- Survival Analysis and Clinicopathological Factors Associated With False-Negative Sentinel Lymph Node Biopsy Findings in Patients with Cutaneous MelanomaAnnals of Surgical Oncology, 2006
- Sentinel-Node Biopsy or Nodal Observation in MelanomaNew England Journal of Medicine, 2006
- Outcome in 846 Cutaneous Melanoma Patients From a Single Center After a Negative Sentinel Node BiopsyAnnals of Surgical Oncology, 2005
- Pathologic Review of Negative Sentinel Lymph Nodes in Melanoma Patients With Regional RecurrenceThe American Journal of Surgical Pathology, 2003
- The definition of the sentinel lymph node in melanoma based on radioactive countsAnnals of Surgical Oncology, 2002
- Outcome of Patients With Melanoma and Histologically Negative Sentinel Lymph NodesArchives of Surgery, 1999
- Lymphoscintigraphy in Malignant MelanomaAnnals of Plastic Surgery, 1992